final action
on 08 Jan 2024
Last Applicant/ Owned by
1 Sansome Street, Suite 3500
San Francisco
CA
94104
Serial Number
97882540 filed on 11th Apr 2023
Registration Number
N/A
Correspondent Address
Norm J. Rich
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Software as a service (SAAS) services featuring software for modeling, rating, scoring and reporting on the conducting of simulations and predictions of properties of drugs or chemicals or vaccines including absorption, release rate, bioavailability, pharmacokinetics and pharmacodynamics, safety, toxicology, and efficacy profiles, routes of administration, and dose optimization; Software as a servRead More
Software as a service (SAAS) services featuring software for modeling, rating, scoring and reporting on the conducting of simulations and predictions of properties of drugs or chemicals or vaccines including absorption, release rate, bioavailability, pharmacokinetics and pharmacodynamics, safety, toxicology, and efficacy profiles, routes of administration, and dose optimization; Software as a service (SAAS) services featuring software that allows for the simulation, prediction, rating, scoring, and reporting of drug-to-drug interactions; Software as a service (SAAS) services featuring software for the simulation, prediction, rating, scoring, and reporting of drug or vaccines or chemical effects on animals and virtual animal or patient populations; Software as a service (SAAS) services featuring software which allows researchers to adjust pharmacodynamic models to observed data and to then use the resulting fitted models to simulate, predict, rate, score, and report on pharmacodynamic changes due to changes in routes of administration, dose, dosage form, and dosing regimen of a drug or chemical or vaccine; Software as a service (SAAS) services featuring software which allow for the prediction, rating, scoring, and reporting of absorption and systemic distribution/elimination for large molecules; Software as a service (SAAS) services featuring software that incorporates artificial intelligence and machine learning to simulate, predict, rate, score, and report on the clinical efficacy of new drugs or chemicals or or vaccines before human trials and accelerate pharmaceutical drug or vaccine development and regulatory approval
30th Sep 2022
30th Sep 2022
No 97882540
No Service Mark
No 117407-0111
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
09th Feb 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
08th Feb 2024 | TEAS AMENDMENT OF USE RECEIVED |
08th Feb 2024 | USE AMENDMENT FILED |
08th Feb 2024 | AMENDMENT TO USE PROCESSING COMPLETE |
08th Jan 2024 | ASSIGNED TO EXAMINER |
08th Jan 2024 | NON-FINAL ACTION WRITTEN |
08th Jan 2024 | NON-FINAL ACTION E-MAILED |
08th Jan 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
05th May 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
14th Apr 2023 | NEW APPLICATION ENTERED |